Stock futures were pointing to a higher opening after the release of better-than-expected retail sales numbers. 

Here are some of the early-market movers for Monday. 

Nabi Biopharmaceuticals (NABI) 

Shares jumped 40% in pre-market trading after the company announced it had entered into a licensing agreement with GlaxoSmithKline (GSK) for Nabi's experimental nicotine additction vaccine, NicVAX. The deal will give Nabi $40 million initially and up to $500 million in additional fees and milestone payments. 

Sprint Nextel Corp (S) 

Analysts at Credit Suisse raised their rating to “outperform” from “neutral.”  Shares were up 9.3% in pre-market trading.

Sinovac Biotech Ltd. (SVA) 

The company announced it was selected by the Shanghai Government to supply its Healive hepatitis A vaccine to the public. The deal is valued at $3 million over the next 12 months. Sinovac shares were up 5% in pre-market trading.

Euroseas Ltd. (ESEA) 

The ocean transport services company released third-quarter results reporting a loss of one cent per share which matched analyst estimates. Revenue of $17.2 million came in above estimates of $13.89 million. Shares were up 4.4% in pre-market trading. 

Citigroup Inc. (C) 

Citigroup shares were up 4% in pre-market trading after the company announced preliminary numbers that show its efforts in Florida have successfully helped distressed homeowners avoid foreclosure at nearly three times the rate from a year ago. 

China Advanced Construction Materials Group, Inc. (CADC) 

Despite posting record quarterly revenue, shares of the Chinese concrete manufacturer were down 23% in pre-market trading after reporting a loss of 44 cents per share for the first quarter. The company had posted earnings of 10 cents per share for the same period last year.